File(s) under embargo
1
month(s)4
day(s)until file(s) become available
Apoptotic cell death in disease - current understanding of the NCCD 2023
Apoptosis is a form of regulated cell death (RCD) that involves proteases of the caspase family. Pharmacological and genetic strategies that experimentally inhibit or delay apoptosis in mammalian systems have elucidated the key contribution of this process not only to (post-)embryonic development and adult tissue homeostasis, but also to the etiology of multiple human disorders. Consistent with this notion, while defects in the molecular machinery for apoptotic cell death impair organismal development and promote oncogenesis, the unwarranted activation of apoptosis promotes cell loss and tissue damage in the context of various neurological, cardiovascular, renal, hepatic, infectious, neoplastic and inflammatory conditions. Here, the Nomenclature Committee on Cell Death (NCCD) gathered to critically summarize an abundant pre-clinical literature mechanistically linking the core apoptotic apparatus to organismal homeostasis in the context of disease.
Funding
Associazione Italiana per la Ricerca sul Cancro (AIRC, IG 2017 #20417 and IG 2022 #27685)
Italian Institute for Genomic Medicine (Candiolo, Turin, Italy)
Compagnia di San Paolo (Torino, Italy)
Ministro dell’Università (Italy) progetto Heal Italia PE6
US DoD BCRP (#BC180476P1; #BC210945)
Transformative Breast Cancer Consortium Grant from the US DoD BCRP (#W81XWH2120034)
U54 grant from NIH/NCI (#CA274291)
2019 Laura Ziskin Prize in Translational Research (#ZP-6177)
Stand Up to Cancer (SU2C)
Mantle Cell Lymphoma Research Initiative (MCL-RI
Leukemia and Lymphoma Society (LLS)
Rapid Response Grant from the Functional Genomics Initiative (New York, US)
Dept. of Radiation Oncology at Weill Cornell Medicine (New York, US)
Lytix Biopharma (Oslo, Norway)
Promontory (New York, US)
Onxeo (Paris, France)
Luke Heller TECPR2 Foundation (Boston, US)
Sotio a.s. (Prague, Czech Republic)
Ricerchiamo (Brescia, Italy)
Noxopharm (Chatswood, Australia)
Ligue contre le Cancer (équipe labellisée)
Agence National de la Recherche (ANR) – Projets blancs
AMMICa US23/CNRS UMS3655
Association pour la recherche sur le cancer (ARC)
Cancéropôle Ile-de-France
Elior
Equipex Onco-Pheno-Screen
European Joint Programme on Rare Diseases (EJPRD)
European Research Council (ICD-Cancer)
European Union Horizon 2020 Projects Oncobiome and Crimson
Fondation Carrefour
Institut National du Cancer (INCa)
Institut Universitaire de France
LabEx Immuno-Oncology (ANR-18-IDEX-0001)
Cancer Research ASPIRE Award from the Mark Foundation
RHU Immunolife
Seerave Foundation
SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE)
SIRIC Cancer Research and Personalized Medicine (CARPEM)
Fondation pour la Recherche Médicale (FRM)
History
Comments
The original article is available at https://www.nature.com/Published Citation
Vitale I. et al. Apoptotic cell death in disease - current understanding of the NCCD 2023. Cell Death Differ. 2023;30(5):1097-1154.Publication Date
26 April 2023External DOI
PubMed ID
37100955Department/Unit
- Physiology and Medical Physics
Publisher
Nature Publishing GroupVersion
- Accepted Version (Postprint)